Dental Drug Reference With Clinical Implications 2nd Edition

An Invitation to Participate in Continuing DentalEducation The purchaser of this text, LWW’s Dental Drug Reference with Clinical Implications, Second Edition, or a single designee, can e

An Invitation to Participate in Continuing Dental

Education

The purchaser of this text, LWW’s Dental Drug Reference with Clinical

Implications, Second Edition, or a single designee, can earn two (2) hours of

Continuing Education (CE) Credit for each of the seven chapters found in the Clinical Medicine and Therapeutics section of the text Participants will earn CE Credit by correctly answering 80% of the questions on a self-administered test The CE tests for this text are offered by the Office of Continuing Education at The University of Texas Health Science Center at San Antonio, Dental School, which

is recognized by The American Dental Association Continuing Education

Recognition Program (ADA CERP) and the Academy of General Dentistry Since CE Credit requirements vary from state to state, participants are encouraged to contact their State Boards for information regarding their state’s specific

requirements.

Participants can take the test(s) electronically for $15.00 per chapter by

registering on the UTHSCSA web site at:

http://smile.uthscsa.edu

To access the Continuing Education courses, click on the CDE Testing Center,

then choose LWW’s Dental Drug Reference from the pull down menu If you are a

first time user you must register Follow the instructions on the screens to

complete the test.

If you have questions about Continuing Education Credits, please contact UTHSCSA directly at:

The University of Texas Health Science Center at San Antonio, Dental School Continuing Dental Education MSC 7930

7703 Floyd Curl Drive

San Antonio, Texas 78229-3900

!NTIBIOTIC 0ROPHYLAXIS FOR $ENTAL 0ATIENTS

WITH 4OTAL *OINT 2EPLACEMENT

*OINT ADVISORY STATEMENT OF THE !MERICAN $ENTAL !SSOCIATION AND THE !MERICAN !CADEMY OF /RTHOPAEDIC 3URGEONS

0!4)%.4 490% #/.$)4)/ 0,!#).' 0!4)%.4 !4 2)3+

!LL PATIENTS DURING ½RST TWO YEARS FOLLOWING OT APPLICABLE

JOINT REPLACEMENT

)MMUNOCOMPROMISEDIMMUNOSUPPRESSED 2HEUMATOID ARTHRITIS

0ATIENTS WITH COMORBIDITIES 0REVIOUS PROSTHETIC JOINT INFECTIONS

-ALNOURISHMENT(EMOPHILIA()6 INFECTION-ALIGNANCY

 "RAUSE  -URRAY AND COLLEAGUES  0OSS AND COLLEAGUES  *ACOBSON AND COLLEAGUES  *OHNSON AND "ANNISTER 

*ACOBSON AND COLLEAGUES  AND "ERBARI AND COLLEAGUES 

#ONDITIONS SHOWN FOR PATIENTS IN THIS CATEGORY ARE EXAMPLES ONLY THERE MAY BE ADDITIONAL CONDITIONS THAT PLACE SUCH PATIENTS AT RISK OF EXPERIENCING HEMATOGENOUS TOTAL JOINT INFECTION

4ABLE  3UGGESTED !NTIBIOTIC 0ROPHYLAXIS 2EGIMENS

0ATIENTS NOT ALLERGIC TO PENICILLIN #EPHALEXIN  G ORALLY  HR PRIOR TO THE DENTAL

CEPHRADRINE PROCEDURE

OR AMOXICILLIN0ATIENTS NOT ALLERGIC TO PENICILLIN #EFAZOLIN OR AMPICILLIN #EFAZOLIN OR AMPICILLIN  G )-AND UNABLE TO TAKE ORAL OR )6  HR PRIOR TO THE DENTAL

0ATIENTS ALLERGIC TO PENICILLIN #LINDAMYCIN  MG ORALLY  HR PRIOR TO THE

DENTAL PROCEDURE0ATIENTS ALLERGIC TO PENICILLIN AND #LINDAMYCIN  MG )6  HR PRIOR TO THEUNABLE TO TAKE ORAL MEDICATION DENTAL PROCEDURE

!DVISORY 3TATEMENT FROM !$! AND !!/3 !NTIBIOTIC PROPHYLAXIS FOR DENTAL PATIENTS WITH TOTAL JOINT REPLACEMENTS *!$!  ¯ 4ABLES  AND  2EPRINTED BY PERMISSION OF !$! 0UBLISHING

 #HING $7 'OULD )- ... the drugs encountered

and used in dentistry, LWW’s Dental Drug Reference with Clinical Implication,

Second Edition, also serves as an up-to-date reference. .. Williams & Wilkins’

Dental Drug Reference< /b>

with Clinical Implications< /b>

Second Edition< /b>

Frieda Atherton... class="page_container" data-page="9">

The second edition of Lippincott Williams and Wilkins’ Dental Drug Reference< /i>

with Clinical Implications is designed as a quick and concise